GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis
出版年份 2021 全文链接
标题
GSTZ1 sensitizes hepatocellular carcinoma cells to sorafenib-induced ferroptosis via inhibition of NRF2/GPX4 axis
作者
关键词
-
出版物
Cell Death & Disease
Volume 12, Issue 5, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2021-04-30
DOI
10.1038/s41419-021-03718-4
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Transcription factors in ferroptotic cell death
- (2020) Chongshan Dai et al. CANCER GENE THERAPY
- Glutathione S-Transferase pi-1 Knockdown Reduces Pancreatic Ductal Adenocarcinoma Growth by Activating Oxidative Stress Response Pathways
- (2020) Rahul R. Singh et al. Cancers
- NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis
- (2019) Matthew Dodson et al. Redox Biology
- Mechanisms of Ferroptosis and Relations With Regulated Cell Death: A Review
- (2019) Pengxu Lei et al. Frontiers in Physiology
- GPX4 at the Crossroads of Lipid Homeostasis and Ferroptosis
- (2019) Giovanni C. Forcina et al. PROTEOMICS
- Targeting Ferroptosis to Iron Out Cancer
- (2019) Behrouz Hassannia et al. CANCER CELL
- GSTZ 1‐1 Deficiency Activates NRF 2/ IGF 1R Axis in HCC via Accumulation of Oncometabolite Succinylacetone
- (2019) Fan Yang et al. EMBO JOURNAL
- A global view of hepatocellular carcinoma: trends, risk, prevention and management
- (2019) Ju Dong Yang et al. Nature Reviews Gastroenterology & Hepatology
- GSTZ1 deficiency promotes hepatocellular carcinoma proliferation via activation of the KEAP1/NRF2 pathway
- (2019) Jingjing Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Systemic therapy for intermediate and advanced hepatocellular carcinoma: Sorafenib and beyond
- (2018) Jean-Luc Raoul et al. CANCER TREATMENT REVIEWS
- The ferroptosis inducer erastin irreversibly inhibits system xc− and synergizes with cisplatin to increase cisplatin’s cytotoxicity in cancer cells
- (2018) Mami Sato et al. Scientific Reports
- Role of ferroptosis in hepatocellular carcinoma
- (2018) Jianhua Nie et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- Molecular therapies and precision medicine for hepatocellular carcinoma
- (2018) Josep M. Llovet et al. Nature Reviews Clinical Oncology
- Iron and cancer: recent insights
- (2016) David H. Manz et al. Annals of the New York Academy of Sciences
- Glutathione-Associated Enzymes In Anticancer Drug Resistance
- (2016) K. D. Tew CANCER RESEARCH
- Improvement of a predictive model in ovarian cancer patients submitted to platinum-based chemotherapy: implications of a GST activity profile
- (2016) Deolinda Pereira et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Metallothionein-1G facilitates sorafenib resistance through inhibition of ferroptosis
- (2016) Xiaofang Sun et al. HEPATOLOGY
- Global survey of cell death mechanisms reveals metabolic regulation of ferroptosis
- (2016) Kenichi Shimada et al. Nature Chemical Biology
- Regulators of Iron Homeostasis: New Players in Metabolism, Cell Death, and Disease
- (2016) Alexander R. Bogdan et al. TRENDS IN BIOCHEMICAL SCIENCES
- Predictive potential role of glutathione S-transferase polymorphisms in the prognosis of breast cancer
- (2015) X. Wang et al. GENETICS AND MOLECULAR RESEARCH
- Activation of the p62-Keap1-NRF2 pathway protects against ferroptosis in hepatocellular carcinoma cells
- (2015) Xiaofang Sun et al. HEPATOLOGY
- Glutathione S-transferase P1 (GSTP1) directly influences platinum drug chemosensitivity in ovarian tumour cell lines
- (2014) L Sawers et al. BRITISH JOURNAL OF CANCER
- In Vivo Regulation of Human Glutathione Transferase GSTP by Chemopreventive Agents
- (2014) C. J. Henderson et al. CANCER RESEARCH
- 3β-Acetyl tormentic acid reverts MRP1/ABCC1 mediated cancer resistance through modulation of intracellular levels of GSH and inhibition of GST activity
- (2014) Gleice da Graça Rocha et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Pharmacological inhibition of cystine–glutamate exchange induces endoplasmic reticulum stress and ferroptosis
- (2014) Scott J Dixon et al. eLife
- Iron-dependent cell death of hepatocellular carcinoma cells exposed to sorafenib
- (2013) Christophe Louandre et al. INTERNATIONAL JOURNAL OF CANCER
- Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growth
- (2012) Hannah van Malenstein et al. CANCER LETTERS
- Ferroptosis: An Iron-Dependent Form of Nonapoptotic Cell Death
- (2012) Scott J. Dixon et al. CELL
- The Incidence and Epidemiology of Hepatocellular Carcinoma: A Global and Regional Perspective
- (2010) A. P. Venook et al. ONCOLOGIST
- Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
- (2008) Ann-Lii Cheng et al. LANCET ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More